{
    "clinical_study": {
        "@rank": "109380", 
        "acronym": "TAPBloc Rachis", 
        "arm_group": [
            {
                "arm_group_label": "treatment", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "control", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective, single-centre, randomised, double-blind trial, comparing TAP block\n      with continuous infiltration of ropivacaine versus placebo.\n\n      Procedure:\n\n      Once consent has been obtained, patients will be randomised into one of the two groups:\n      Ropivacaine or Placebo. At the end of the operation, the TAP block will be implemented via a\n      catheter inserted by the anaesthetist."
        }, 
        "brief_title": "The Tap Block Technique Via the Anterior Approach in Elective Surgery of the Spine", 
        "condition": "Elective Surgery of the Spine by Laparotomy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients over 18 yo who have provided written informed consent\n\n          -  Patients with an indication for elective spinal surgery using laparotomy\n\n          -  Patients with national health insurance  cover\n\n        Exclusion Criteria:\n\n          -  Adults under guardianship\n\n          -  Pregnant or breast-feeding women\n\n          -  allergies or contra-indication for paracetamol, morphine-based drugs\n\n          -  Contra-indication for ropivacaine\n\n          -  Contra-indication for sodium chloride\n\n          -  inability to understand PCA (patient-controlled anaesthesia)\n\n          -  Hypersensitivity to ropivacaine or to other aminoamide local anaesthetics\n\n          -  Hypovolemia"
            }, 
            "gender": "Both", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02055664", 
            "org_study_id": "MIREK 2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "control", 
                "intervention_name": "Ropivacaine 0.2%", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "treatment", 
                "intervention_name": "Chlorure de sodium 0.9%", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "contact": {
                "email": "sebastien.mirek@chu-dijon.fr", 
                "last_name": "Sebastien MIREK", 
                "phone": "3.80.29.30.31", 
                "phone_ext": "+33"
            }, 
            "facility": {
                "address": {
                    "city": "Dijon", 
                    "country": "France", 
                    "zip": "21079"
                }, 
                "name": "CHU de Dijon"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "THE TAP BLOCK TECHNIQUE VIA THE ANTERIOR APPROACH IN ELECTIVE SURGERY OF THE SPINE: Prospective, Randomised, Double Blind Trial, Comparing TAP BLOCK With Continuous Infiltration of Ropivacaine Versus Placebo", 
        "overall_contact": {
            "email": "sebastien.mirek@chu-dijon.fr", 
            "last_name": "Sebastien MIREK", 
            "phone": "3.80.29.30.31", 
            "phone_ext": "+33"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Consumption of morphine in mg", 
            "safety_issue": "No", 
            "time_frame": "First 48 hours following the surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02055664"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Intensity of pain", 
            "safety_issue": "No", 
            "time_frame": "First 48 hours following the surgery"
        }, 
        "source": "Centre Hospitalier Universitaire Dijon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire Dijon", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}